Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enerkem is a leading industrial biotechnology company that has developed a proprietary thermochemical platform to convert non-recyclable municipal solid waste into renewable biofuels and circular chemicals. Headquartered in Montreal, the company utilizes a high-severity gasification process to produce syngas, which is then catalytically converted into methanol, ethanol, and other chemical intermediates. This technology provides a sustainable alternative to landfilling and incineration, significantly reducing greenhouse gas emissions for the transportation and chemical sectors. Enerkem operates a commercial-scale facility in Edmonton and is currently developing the Varennes Carbon Recycling project in Quebec. The company's business model focuses on both the direct production of renewable fuels and the global licensing of its technology to enable a circular economy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enerkem.